Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Common Stock, par value $0.001 per share · CUSIP: 00166B105

Event date: 2025-10-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 2,730,504.00 · Class: 5.1%

  • Millennium Management LLC

    Shares: 3,188,196.00 · Class: 6.0%

  • Millennium Group Management LLC

    Shares: 3,188,196.00 · Class: 6.0%

  • Israel A. Englander

    Shares: 3,188,196.00 · Class: 6.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-101541
Form type
SCHEDULE 13G/A
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Oct 22, 2025
Reporting period
Oct 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub